tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cellectar Biosciences Plans Phase 1 Cancer Studies
PremiumCompany AnnouncementsCellectar Biosciences Plans Phase 1 Cancer Studies
2M ago
Cellectar Biosciences files to sell 755,667 Class A Units
Premium
The Fly
Cellectar Biosciences files to sell 755,667 Class A Units
2M ago
Cellectar Biosciences, Nusano enter into multi-isotope supply agreement
Premium
The Fly
Cellectar Biosciences, Nusano enter into multi-isotope supply agreement
2M ago
Cellectar Biosciences announces 1-for-30 reverse stock split
PremiumThe FlyCellectar Biosciences announces 1-for-30 reverse stock split
2M ago
Cellectar Biosciences Approves Reverse Stock Split Proposal
Premium
Company Announcements
Cellectar Biosciences Approves Reverse Stock Split Proposal
2M ago
Cellectar Biosciences provides update on CLOVER-2 Phase 1 trial
Premium
The Fly
Cellectar Biosciences provides update on CLOVER-2 Phase 1 trial
2M ago
Cellectar announces U.S. FDA granted BTD for iopofosine I 131
PremiumThe FlyCellectar announces U.S. FDA granted BTD for iopofosine I 131
3M ago
Merck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
Premium
Weekend Updates
Merck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
3M ago
Cellectar Biosciences Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Cellectar Biosciences Earnings Call: Progress Amid Challenges
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100